[ad_1]
The American biotechnology company Moderna announced that the corona virus vaccine they developed was uncomplicated and that an emergency use permit would be applied with a 94.1 percent success rate.
MADE WITH 30 THOUSAND PEOPLE
In vaccine studies with more than 30,000 people, Moderna said 185 of 196 coronavirus patients received the vaccine and 11 of them received a placebo. Thirty cases among these patients were reported as severe cases. Moderna announced that the vaccine was effective in all of these thirty people.
Leading Moderna’s vaccination team, Dr. “We believe we have an extremely effective vaccine. We now have the data to prove it,” Tal Zaks said in a statement, saying: “We hope to play an important role in eradicating this epidemic.” .
‘IT IS NOT A STATISTICALLY SIGNIFICANT DIFFERENCE’
Explaining the effectiveness rate as 94.5 percent on November 16 and stated as 94.1 in the figure announced today, Dr. Tal Zaks stated that this relationship is not a statistically significant difference.
Moderna is on the case for the second vaccine that applied for emergency use permission after the Pfizer-Biontech vaccine, which requested emergency use last week. The effectiveness of the Pfizer-Biontech vaccine was announced at 95 percent.
RESULTS ON DECEMBER 17
Independent consultants from the US Food and Drug Administration will meet on December 17 to review Moderna’s vaccine studies. It was previously announced that officials would meet on December 10 to review Pfizer’s data.
